Literature DB >> 11313968

The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-kappaB activation.

J Gil1, J Rullas, M A García, J Alcamí, M Esteban.   

Abstract

The double stranded RNA-dependent protein kinase (PKR), in addition to its role as a translational controlling factor, is a key transcriptional regulator exerting antiviral and antitumoral activities. We have previously shown that induction of NF-kappaB by PKR is involved in apoptosis commitment and this process is mediated through activation of the IKK complex. To gain insights into the mechanism of activation of NF-kappaB by PKR, we have analysed the domains of PKR involved in IKK activation and subsequent NF-kappaB induction. In PKR(0/0) cells infected with a collection of vaccinia virus (VV) recombinants expressing different mutant forms of PKR, we found that only PKR forms conserving the catalytic activity are able to activate NF-kappaB. An inactive PKR mutant (K296R), was unable to induce NF-kappaB activation despite full expression of the protein in a wide range of concentrations, as defined by Western blot, EMSA, IKK kinase activity and NF-kappaB transactivation assays. Moreover, the mutant PKR (K296R) acts as a dominant negative of PKR-induced eIF-2alpha phosphorylation and NF-kappaB activation. However, PKR mutants unable to activate NF-kappaB still retain their ability to associate with the IKK complex, as confirmed by immunoprecipitation analysis. We conclude that the catalytic activity of PKR and not only a protein-protein interaction with the IKK complex, is needed for activation of the transcription factor NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313968     DOI: 10.1038/sj.onc.1204109

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  TRAF family proteins link PKR with NF-kappa B activation.

Authors:  Jesús Gil; Maria Angel García; Paulino Gomez-Puertas; Susana Guerra; Joaquín Rullas; Hiroyasu Nakano; José Alcamí; Mariano Esteban
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

2.  Toll-like receptor ligands directly promote activated CD4+ T cell survival.

Authors:  Andrew E Gelman; Jidong Zhang; Yongwon Choi; Laurence A Turka
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

3.  NF-κB Activation Promotes Alphavirus Replication in Mature Neurons.

Authors:  Jane X Yeh; Eunhye Park; Kimberly L W Schultz; Diane E Griffin
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

4.  Virus infection rapidly activates the P58(IPK) pathway, delaying peak kinase activation to enhance viral replication.

Authors:  Alan G Goodman; Bertrand C W Tanner; Stewart T Chang; Mariano Esteban; Michael G Katze
Journal:  Virology       Date:  2011-05-25       Impact factor: 3.616

Review 5.  The heat shock response and cytoprotection of the intestinal epithelium.

Authors:  Joshua J Malago; Jos F J G Koninkx; Jaap E van Dijk
Journal:  Cell Stress Chaperones       Date:  2002-04       Impact factor: 3.667

6.  Cytoplasmic RNA Granules and Viral Infection.

Authors:  Wei-Chih Tsai; Richard E Lloyd
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

Review 7.  NF-kappaB and virus infection: who controls whom.

Authors:  M Gabriella Santoro; Antonio Rossi; Carla Amici
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

8.  Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses.

Authors:  Hao-Yuan Jiang; Sheree A Wek; Barbara C McGrath; Donalyn Scheuner; Randal J Kaufman; Douglas R Cavener; Ronald C Wek
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

Review 9.  Old target new approach: an alternate NF-kappaB activation pathway via translation inhibition.

Authors:  Csaba F László; Shiyong Wu
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

10.  The virion host shutoff RNase plays a key role in blocking the activation of protein kinase R in cells infected with herpes simplex virus 1.

Authors:  Maria Teresa Sciortino; Tiziana Parisi; Gabriel Siracusano; Antonio Mastino; Brunella Taddeo; Bernard Roizman
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.